🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Sirukumab is a fully human anti-interleukin-6 (IL-6) immunoglobulin G1-kapp...
Status
Terminated
Location
GSK Investigational Site
Start Date
2015-10-16
Trial ID
NCT02531633
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of tenofovi...
Status
Completed
Location
Midway Immunology and Research center
Start Date
2013-10-25
Trial ID
NCT01967940
Treatments Being Tested
FLU-v is a vaccine that aims to protect against a wide range of flu viruses...
Status
Completed
Location
Isala
Start Date
2016-08
Trial ID
NCT02962908
Treatments Being Tested
The aim of this early phase two-part study was to compare the bioavailabili...
Status
Completed
Location
Quotient Sciences Ltd
Start Date
2021-11-26
Trial ID
NCT06028321
Treatments Being Tested
This study is to evaluate copeptin values after the subcutaneous injection ...
Status
Completed
Location
Divison of Endocrinology, Diabetes and Metabolism,University Hospital Basel
Start Date
2020-09-28
Trial ID
NCT04550520
This is a Phase 2, randomized, double-blind, placebo-controlled, multicente...
Status
Recruiting
Location
Gastro Care Institute
Start Date
2024-07-18
Trial ID
NCT06226883
The primary purpose of this first-in-man study is to investigate whether AC...
Status
Terminated
Location
Covance Clinical Research Unit
Start Date
2016-09-12
Trial ID
NCT02905253
The purpose of this study is to evaluate morphine intake in the first 4 hou...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2003-04
Trial ID
NCT00651300
Treatments Being Tested
To assess the effects of REGN3500, dupilumab, and REGN3500 plus dupilumab, ...
Status
Completed
Location
WCCT Global
Start Date
2017-06-15
Trial ID
NCT03112577
Treatments Being Tested
The purpose of this study is to evaluate pharmacokinetics, safety, tolerabi...
Status
Terminated
Location
Multiple Locations
Start Date
2015-12-04
Trial ID
NCT02593851
Treatments Being Tested